Magnesium pyridoxal 5-phosphate glutamate
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(2S)-2,5-diamino-5-oxopentanoic acid; (4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl dihydrogen phosphate | |
| Clinical data | |
| Trade names | Sedalipid |
| Identifiers | |
| CAS Number | 62055-05-4 (magnesium salt) |
| ATC code | C10AX07 (WHO) |
| PubChem | CID 173846 |
| ChemSpider |
151728 |
| Chemical data | |
| Formula | C13H20N3O9P |
| Molar mass | 393.286 g/mol |
| |
| |
| (verify) | |
Magnesium pyridoxal 5-phosphate glutamate (trade name Sedalipid) is a hypolipidemic agent.[1]
References
- ↑ Schuitemaker GE, van der Pol GA, Aretz CP, Dinant GJ (2001). "A placebo-controlled, double-blind, randomised trial of magnesium-pyridoxal-5'-phosphate-glutamate for hypercholesterolaemia and other clinical-chemical risk factors of cardiovascular disease in a primary care setting". Eur. J. Clin. Pharmacol. 56 (12): 857–63. doi:10.1007/s002280000247. PMID 11317472.
| ||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
